VTYX – ventyx biosciences, inc. (US:NASDAQ)
Stock Stats
News
Ventyx Biosciences to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
Ventyx Biosciences, Inc. (NASDAQ: VTYX) had its "neutral" rating re-affirmed by analysts at HC Wainwright.
Ventyx Biosciences Highlights 2025 Pipeline Strategy and Provides Clinical Updates on its NLRP3 Inhibitor Portfolio [Yahoo! Finance]
Ventyx Biosciences Highlights 2025 Pipeline Strategy and Provides Clinical Updates on its NLRP3 Inhibitor Portfolio
VENTYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Ventyx Biosciences, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Form SCHEDULE 13G Ventyx Biosciences, Inc. Filed by: BANK OF AMERICA CORP /DE/
Form SCHEDULE 13G/A Ventyx Biosciences, Inc. Filed by: Flynn James E
Form SCHEDULE 13G Ventyx Biosciences, Inc. Filed by: Sio Capital Management, LLC
Form SCHEDULE 13G Ventyx Biosciences, Inc. Filed by: Point72 Asset Management, L.P.
Form 8-K Ventyx Biosciences, Inc. For: Jan 14
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.